Squarepoint
PRCT icon

Squarepoint’s Procept Biorobotics PRCT Stock Holding History

Squarepoint’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Buy
+26,430
New +$662K ﹤0.01% 3286
2026
Q1 		– Sell
-191,581
Closed -$6.03M – 4816
2025
Q4 		$6.03M Buy
+191,581
New +$6.35M 0.01% 1341
2025
Q3 		– Sell
-159,600
Closed -$7.29M – 4857
2025
Q2 		$9.19M Sell
159,600
-61,669
-28% -$3.49M 0.01% 1112
2025
Q1 		$12.9M Buy
221,269
+129,494
+141% +$8.84M 0.02% 904
2024
Q4 		$7.39M Buy
91,775
+15,484
+20% +$1.32M 0.01% 1338
2024
Q3 		$6.11M Buy
76,291
+29,818
+64% +$2.12M 0.01% 1277
2024
Q2 		$2.84M Buy
46,473
+12,077
+35% +$718K ﹤0.01% 1788
2024
Q1 		$1.7M Buy
34,396
+27,531
+401% +$1.31M ﹤0.01% 2194
2023
Q4 		$288K Sell
6,865
-22,517
-77% -$767K ﹤0.01% 3390
2023
Q3 		$964K Buy
+29,382
New +$1M ﹤0.01% 2344
2023
Q2 		– Sell
-52,746
Closed -$1.5M – 3910
2023
Q1 		$1.5M Buy
52,746
+25,980
+97% +$916K 0.01% 1615
2022
Q4 		$1.11M Buy
+26,766
New +$1.15M ﹤0.01% 1748
2021
Q4 		– Sell
-26,549
Closed -$1.01M – 3449
2021
Q3 		$1.01M Buy
+26,549
New +$1.02M ﹤0.01% 1556

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Squarepoint's PRCT Position: Q2 2026 in Review

Squarepoint opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 26,430 shares worth $597K. The stake represents ﹤0.01% of the portfolio and ranks #3286 among its holdings. This is a return to the name: Squarepoint previously reported a position in PRCT as recently as Q4 2025.

Squarepoint first reported a position in PRCT in Q3 2021 and has held it in 13 quarters since. The position peaked at $12.9M in Q1 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Squarepoint held 26,430 shares of Procept Biorobotics worth $597K as of Q2 2026.
  • Procept Biorobotics was a new Squarepoint position in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3286 holding.
  • Squarepoint first reported a position in Procept Biorobotics in Q3 2021 and has held it in 13 quarters since.
  • Squarepoint's Procept Biorobotics position peaked at $12.9M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.